This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovator Tsutomu Henta: Pioneering Research in Diabetes Therapeutics
Introduction
Tsutomu Henta is a notable inventor based in Osaka, Japan, recognized for his significant contributions to the field of healthcare and pharmaceuticals. With one patented invention, Tsutomu has made strides in developing methods to address critical health issues such as diabetes and related diseases.
Latest Patents
Tsutomu Henta holds a patent titled "Methods for screening insulin-sensitizing agents." This innovative patent describes a compound or its salt that inhibits the activity of a protein with an amino acid sequence similar to that represented by SEQ ID NO: 1. This discovery indicates that various agents, including extracellular domains of the protein, antibodies, and antisense polynucleotides, can serve as insulin-sensitizing agents. Furthermore, these agents show potential in preventing and treating conditions such as diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, and heart disease.
Career Highlights
Tsutomu Henta is currently associated with Takeda Pharmaceutical Company Limited, a leading global company in the pharmaceutical sector. His expertise and focus on innovative therapeutic approaches have positioned him as a valuable asset to the organization, contributing to its mission of advancing healthcare solutions.
Collaborations
Throughout his career, Tsutomu has had the opportunity to collaborate with esteemed colleagues, including Hideaki Tojo and Reiko Sasada. These collaborations have fostered an environment of shared knowledge and innovation, further enhancing the research outputs in health-related inventions.
Conclusion
In summary, Tsutomu Henta stands out as a proactive inventor dedicated to improving health outcomes through his research and patented inventions. His work at Takeda Pharmaceutical Company Limited and collaborative efforts with other professionals continue to influence advancements in diabetes therapeutics and beyond. Tsutomu’s contributions represent a significant step towards innovative solutions that address pressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile